The emergence of clinical resistance to tigecycline

被引:215
作者
Sun, Yan [1 ]
Cai, Yun [1 ]
Liu, Xu [1 ]
Bai, Nan [1 ]
Liang, Beibei [1 ]
Wang, Rui [1 ]
机构
[1] Peoples Liberat Army Gen Hosp, Dept Clin Pharmacol, Beijing 100853, Peoples R China
基金
北京市自然科学基金; 中国国家自然科学基金;
关键词
Tigecycline; Multidrug resistance; Mechanism; IN-VITRO ACTIVITY; BACTEROIDES-FRAGILIS GROUP; MULTIDRUG EFFLUX PUMP; INTENSIVE-CARE-UNIT; ACINETOBACTER-BAUMANNII; ANTIMICROBIAL RESISTANCE; KLEBSIELLA-PNEUMONIAE; STENOTROPHOMONAS-MALTOPHILIA; DECREASED SUSCEPTIBILITY; STAPHYLOCOCCUS-AUREUS;
D O I
10.1016/j.ijantimicag.2012.09.005
中图分类号
R51 [传染病];
学科分类号
100201 [内科学];
摘要
Tigecycline (TIG) exhibits broad-spectrum activity against many Gram-positive and Gram-negative pathogens. However, clinical resistance has emerged recently and has been detected following treatment with TIG. This observation suggests that long-term monotherapy may carry a high risk for TIG resistance. TIG resistance is observed most frequently in Acinetobacter baumannii and Enterobacteriaceae, especially in multidrug-resistant strains. Resistance-nodulation-cell division (RND)-type transporters and other efflux pumps may be factors for decreased sensitivity to TIG. Therefore, TIG should be cautiously used in the clinic, and efflux-mediated resistance should be closely monitored in order to prolong the lifespan of this useful antibiotic. (C) 2012 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:110 / 116
页数:7
相关论文
共 86 条
[1]
Evolution of tigecycline resistance in Klebsiella pneumoniae in a single patient [J].
Al Qadheeb, Nada S. ;
Althawadi, Sahar ;
Alkhalaf, Abdulaziz ;
Hosaini, Suleiman ;
Alrajhi, Abdulrahman A. .
ANNALS OF SAUDI MEDICINE, 2010, 30 (05) :404-407
[2]
An outbreak of CTX-M-15-producing Klebsiella pneumoniae isolates in an intensive care unit of a teaching hospital in Kuwait [J].
Al Sweih, N. ;
Salama, M. F. ;
Jamal, W. ;
Al Hashem, G. ;
Rotimi, V. O. .
INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2011, 29 (02) :130-135
[3]
Emergence of Tigecycline and Colistin Resistance in Acinetobacter Species Isolated from Patients in Kuwait Hospitals [J].
Al-Sweih, N. A. ;
Al-Hubail, M. A. ;
Rotimi, V. O. .
JOURNAL OF CHEMOTHERAPY, 2011, 23 (01) :13-16
[4]
Determining In Vitro Synergistic Activities of Tigecycline with Several Other Antibiotics against Brucella melitensis Using Checkerboard and Time-Kill Assays [J].
Aliskan, H. ;
Can, F. ;
Demirbilek, M. ;
Colakoglu, S. ;
Kilic, S. ;
Arslan, H. .
JOURNAL OF CHEMOTHERAPY, 2009, 21 (01) :24-30
[5]
Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline [J].
Anthony, Kara B. ;
Fishman, Neil O. ;
Linkin, Darren R. ;
Gasink, Leanne B. ;
Edelstein, Paul H. ;
Lautenbach, Ebbing .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (04) :567-570
[6]
Tigecycline in vitro activity against commonly encountered multidrug-resistant Gram-negative pathogens in a Middle Eastern country [J].
Araj, George F. ;
Ibrahim, Georges Y. .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2008, 62 (04) :411-415
[7]
Investigation of the prevalence of tetQ, tetX and tetX1 genes in Bacteroides strains with elevated tigecycline minimum inhibitory concentrations [J].
Bartha, Noemi Aniko ;
Soki, Jozsef ;
Edit Urban ;
Nagy, Elisabeth .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 38 (06) :522-525
[8]
Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drug-directed Fe2+ cleavage of 16S rRNA [J].
Bauer, G ;
Berens, C ;
Projan, SJ ;
Hillen, W .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (04) :592-599
[9]
Behera B, 2009, INDIAN J MED RES, V129, P446
[10]
In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae [J].
Bercot, Beatrice ;
Poirel, Laurent ;
Dortet, Laurent ;
Nordmann, Patrice .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (10) :2295-2297